Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study
Saved in:
| Published in: | Open Forum Infectious Diseases |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1870297419628937216 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Open Forum Infectious Diseases |
| description | |
| discipline_display | Communicable Diseases, Epidemiology |
| discipline_facet | Communicable Diseases, Epidemiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:101682 |
| institution | FRELIP |
| journal_source_facet | Open Forum Infectious Diseases |
| last_indexed | 2026-07-10T03:36:52.846Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| subject_facet | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| title | Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study |
| title_alt | Terapia antirretroviral basada en dolutegravir una vez al día en adultos con enfermedad avanzada por VIH que reciben un mes de rifapentina e isoniazida diarias para la terapia preventiva de tuberculosis y fluconazol para el tratamiento de la meningitis criptocócica: resultados de un estudio farmacocinético Thérapie antirétrovirale à base de dolutégravir une fois par jour chez les adultes atteints de maladie VIH avancée recevant un mois de rifapentine et isoniazide quotidiens pour la prophylaxie de la tuberculose et du fluconazole pour le traitement de la méningite cryptococcique : résultats d'une étude pharmacocinétique Terapia antirretroviral baseada em dolutegravir uma vez ao dia entre adultos com doença avançada por HIV recebendo 1 mês de rifapentina e isoniazida diárias para terapia preventiva de TB e fluconazol para tratamento de meningite criptocócica: resultados de um estudo farmacocinético |
| title_auth | Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study |
| title_es_txt | Terapia antirretroviral basada en dolutegravir una vez al día en adultos con enfermedad avanzada por VIH que reciben un mes de rifapentina e isoniazida diarias para la terapia preventiva de tuberculosis y fluconazol para el tratamiento de la meningitis criptocócica: resultados de un estudio farmacocinético |
| title_fr_txt | Thérapie antirétrovirale à base de dolutégravir une fois par jour chez les adultes atteints de maladie VIH avancée recevant un mois de rifapentine et isoniazide quotidiens pour la prophylaxie de la tuberculose et du fluconazole pour le traitement de la méningite cryptococcique : résultats d'une étude pharmacocinétique |
| title_full | Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study |
| title_fullStr | Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study |
| title_full_unstemmed | Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study |
| title_pt_txt | Terapia antirretroviral baseada em dolutegravir uma vez ao dia entre adultos com doença avançada por HIV recebendo 1 mês de rifapentina e isoniazida diárias para terapia preventiva de TB e fluconazol para tratamento de meningite criptocócica: resultados de um estudo farmacocinético |
| title_short | Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study |
| title_sort | once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced hiv disease receiving 1-month of daily rifapentine and isoniazid for tb preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study |
| topic | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| url | https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofag415/8728422?rss=1 |